Pyrimidine derivatives for inhibition of cell proliferation

Details Pyrimidine derivatives for inhibition of cell proliferation Pyrimidine derivatives for inhibition of cell proliferation

2005-01-18

2005-01-18

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S249000, C514S259100, C544S236000, C544S281000, C544S350000

Reexamination Certificate

active

06844341

ABSTRACT:
Compounds of the formula (I): wherein Ring A, R1, R3, R4, p, q, and n are as defined within and a pharmaceutically acceptable salts and in vivo hydrolyzable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-quest-blooded animal, such as man.

REFERENCES:
patent: 4983608 (1991-01-01), Effland et al.
patent: 5516775 (1996-05-01), Zimmermann et al.
patent: 5521184 (1996-05-01), Zimmermann
patent: 5610303 (1997-03-01), Kimura et al.
patent: 5739143 (1998-04-01), Adams et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 6593326 (2003-07-01), Bradbury et al.
patent: 6632820 (2003-10-01), Breault et al.
patent: 6649608 (2003-11-01), Pease et al.
patent: 6670368 (2003-12-01), Breault
patent: 2231765 (1998-09-01), None
patent: 0 135 472 (1985-03-01), None
patent: 0 363 002 (1990-04-01), None
patent: 0 379 806 (1990-08-01), None
patent: 0 945 443 (1999-09-01), None
patent: 9118887 (1991-12-01), None
patent: 9220642 (1992-11-01), None
patent: 9509847 (1995-04-01), None
patent: 9509851 (1995-04-01), None
patent: 9509852 (1995-04-01), None
patent: 9509853 (1995-04-01), None
patent: 9615952 (1995-06-01), None
patent: 9605177 (1996-02-01), None
patent: 9628427 (1996-09-01), None
patent: 9640143 (1996-12-01), None
patent: 9719065 (1997-05-01), None
patent: 9735856 (1997-10-01), None
patent: 9740017 (1997-10-01), None
patent: 9744326 (1997-11-01), None
patent: 9747618 (1997-12-01), None
patent: 9811095 (1998-03-01), None
patent: 9816230 (1998-04-01), None
patent: 9818782 (1998-05-01), None
patent: 9825619 (1998-06-01), None
patent: 9833798 (1998-08-01), None
patent: 9841512 (1998-09-01), None
patent: 9854093 (1998-12-01), None
patent: 9856788 (1998-12-01), None
patent: 9901136 (1999-01-01), None
patent: 9932121 (1999-01-01), None
patent: 9918096 (1999-04-01), None
patent: 9918942 (1999-04-01), None
patent: 9931073 (1999-06-01), None
patent: 9941253 (1999-08-01), None
patent: 9950250 (1999-10-01), None
patent: 9950251 (1999-10-01), None
patent: 0012485 (2000-03-01), None
patent: 0012486 (2000-03-01), None
patent: 0017202 (2000-03-01), None
patent: 0017203 (2000-03-01), None
patent: 0021926 (2000-04-01), None
patent: 0025780 (2000-05-01), None
patent: 0026209 (2000-05-01), None
patent: 0039101 (2000-06-01), None
patent: 0044750 (2000-08-01), None
patent: 0049018 (2000-08-01), None
patent: 0053592 (2000-09-01), None
patent: 0055161 (2000-09-01), None
patent: 0059892 (2000-10-01), None
patent: 0078731 (2000-12-01), None
patent: 0114375 (2001-03-01), None
patent: 0129009 (2001-04-01), None
patent: 0130778 (2001-05-01), None
patent: 0137835 (2001-05-01), None
patent: 0147897 (2001-07-01), None
patent: 0147921 (2001-07-01), None
patent: 0160816 (2001-08-01), None
patent: 0164653 (2001-09-01), None
patent: 0164654 (2001-09-01), None
patent: 0164655 (2001-09-01), None
patent: 0164656 (2001-09-01), None
patent: 0172717 (2001-10-01), None
patent: 0204429 (2002-01-01), None
patent: 0220512 (2002-03-01), None
patent: 02096887 (2002-12-01), None
Volin et al., Cell Cycle Implications in the Pathogenesis of Rheumatoid Arthritis, Frontiers in Bioscience 5, d594-601, Jun. 2000.*
Blain et al., Differential Interaction of the Cyclin-dependent Kinase (CDK) Inhibitor p27Kip 1 with Cyclin A-CDK2 and Cyclin D2-CDK4, The J. of Biol. Chem., vol. 272, No. 41, pp. 25863-25872, Oct. 1997.*
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.*
Boschelli et al., Synthesis and Tyrosine Kinase Inhibitory Activity of a Series of 2-Amino-8-H-pyrido[2,3-d]pyrimidines: Identifidation of Potent, Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitors, J. Med. Chem., vol. 41, 1998, pp. 4365-4377.
Deady et al., “Reactions of some Quinazoline Compounds with Ethoxymethylenemalonic Acid Derivatives”, J. Heterocyclic Chem., vol. 26, 1989, pp. 161-168.
El-Kerdawy et al.; “2,4-Bis (Substituted)-5-Nitropyrimidines of Expected Diuretic Action”; Egypt J. Chem. vol. 29, No. 2, 1986, pp. 247-251.
Fiziol Akt Veshchestva, 1975, vol. 7, pp. 68-72.
Ghosh et al.; “2,4-Bis(arylamino)-5-methylpyrimidines as Antimicrobial Agents”; J. Med. Chem., 1967, vol. 10, No. 5, pp. 974-975.
Ghosh, “2,4-Bis(arylamino)-6-methylpyrimidines as an antimicrobial agents”, Chemical Abstract No. 97712f, vol. 95, 1981, pp. 648.
Schmidt et al.; “A Convenient Synthesis of 2-substituted 4-Amino-5-pyrimidinecarbonitriles”; J. Heterocycle Chem., 1997, vol. 24, No. 5, pp. 1305-1307.
Zimmermann et al., Phenylamino-Pyrimidine (PAP) Derivatives: A New Class of Potent and Selective Inhibitors of Protein Kinase C (PKC), Arch. Pharm. Pharm. Med. Chem., vol. 329, 1996, pp. 371-376.

Affiliated with

Also associated with

Rating

Pyrimidine derivatives for inhibition of cell proliferation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine derivatives for inhibition of cell proliferation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives for inhibition of cell proliferation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3430210